VAV to support academic research in lipid nanomedicine EP News Bureau Mar 24, 2022 The company has announced a slew of research benefits to universities and academic institutions around the world that take up…
VAV Life Sciences receives COSMOS approval from Ecocert for cosmetics ingredients EP News Bureau Feb 10, 2022 The COSMOS approval will allow VAV’s natural cosmetics ingredients to be marketed and commercialised worldwide
VAV expands capacity for COVID-19 lipids EP News Bureau Nov 24, 2021 The company invests Rs 15 crores to boost capacity to meet overseas demand for specialised lipids used in COVID-19 vaccines and…
From HIV to COVID-19: The role of liposomal nanotechnology as an NDDS of choice EP News Bureau Aug 6, 2021 Arun Kedia, Managing Director, VAV Life Sciences, elaborates how NDDS have proved to be beneficial with applications across…
Supplied lipids for about three lakh vials of Amphotericin B formulations: VAV Life Sciences EP News Bureau Jun 30, 2021 VAV expects to triple the quantity by December 2021
VAV Life Sciences ramps up production of crucial lipid ingredients needed for amphotericin-B EP News Bureau May 25, 2021 VAV expects with an increased capacity, its lipid raw materials will help pharma companies to add three lakh vials of liposomal…